Anti-Alpha, Delta, and Omicron mAb therapy lowers the chance of hospitalization and death.
Researchers evaluate the efficacy of monoclonal antibodies (mAbs) in treating coronavirus disease 2019 (COVID-19) caused by various viral variants in a recent study published in the Annals of Internal Medicine. …
Anti-Alpha, Delta, and Omicron mAb therapy lowers the chance of hospitalization and death. Read More